GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RADNOSTIX, INC. INIS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.04

+2.56%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About RADNOSTIX, INC.

From its filings with the US Securities and Exchange Commission

SEC filings

RADNOSTIX, INC. is based in Idaho Falls, Idaho and is incorporated in Texas. Its shares trade on OTC under the ticker INIS. The SEC classifies its business as industrial instruments for measurement, display, and control. In the fiscal year to 31 December 2025, it reported revenue of $13.1m and a net loss of $908,002. At that date it held total assets of $17.8m and shareholders' equity of $3.7m.

In its own words

Radnostix Inc. (the “Company”, “we”, “us” and “our”) manufactures a wide range of radioisotope-focused products used in variety of medical and industrial applications. We were formed as a Texas corporation in 1995. On December 23, 2025, we filed a Certificate of Amendment in the state of Texas for the sole purpose of amending our Certificate of Formation to change our corporate name from International Isotopes Inc. to Radnostix, Inc. Our board of directors approved the name change on October 21, 2025, and a majority of shareholders approved the name change by written consent on November 25, 2025.

Our wholly-owned subsidiaries are International Isotopes Idaho Inc., a Texas corporation; International Isotopes Fluorine Products, Inc., an Idaho corporation; International Isotopes Transportation Services, Inc., an Idaho corporation; RadQual, LLC, a limited liability company (RadQual); RadVent, LLC, a limited liability company; and TI Services, LLC, a limited liability company (TI Services). Our core business consists of five reportable segments which include: Theranostics Products, Cobalt Products, Calibration & Reference Products (previously called Nuclear Medicine Standards), Medical Devices, and Fluorine Products.

Quoted from its 10-K, filed 31 Mar 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
14 Aug 1997
Employees
44
Head office
4137 COMMERCE CIRCLE, IDAHO FALLS, ID, 83401
Incorporated in
TX
Classification
Industrial Instruments For Measurement, Display, and Control
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Christopher GrossoIndependent Chairman of the Board$41,980
  • Mr. Shahe BagerdjianPresident, Chief Executive Officer, Director, since 2023$429,702
  • Mr. W. Matthew CoxChief Financial Officer, Secretary$148,654
  • Mr. Steve LaflinDirector, since 2001$378,625
  • Dr. Robert AtcherIndependent Director$108,304
  • Mr. David DrewitzInvestor Relations, since 2013

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.